Results 131 to 140 of about 1,957 (165)
Some of the next articles are maybe not open access.
In Brief: A New Torsemide Formulation (Soaanz) for Edema
The Medical Letter on Drugs and TherapeuticsThe FDA has approved Soaanz (Sarfez), a new formulation of the loop diuretic torsemide, for treatment of edema associated with heart failure or renal disease in adults. Torsemide has been available generically for years for treatment of hypertension and treatment of edema due to heart failure, renal disease, or hepatic disease.
openaire +2 more sources
Torsemide-Induced Pseudoporphyria
Archives of Dermatology, 2008Alicia Pérez-Bustillo +3 more
openaire +1 more source
An evaluation of torsemide in patients with heart failure and renal disease
Expert Review of Cardiovascular Therapy, 2022Stephen Greene +2 more
exaly
Stability of torsemide in 5% dextrose injection
American Journal of Health-System Pharmacy, 1998P A, Montgomery +3 more
openaire +2 more sources

